Automated Suturing Devices Market Size, Share, Key Players Analysis, Growth Factors, New Technology, Application and Regional Forecast 2022 to 2032
In recent years, the field of surgery has witnessed remarkable advancements in technology, and one area that has seen significant progress is the development of Automated Suturing Devices Market These innovative tools have revolutionized the way surgeons perform suturing, offering numerous benefits over traditional manual techniques.
Automated suturing devices are sophisticated instruments that can precisely and efficiently close surgical incisions and wounds. They are designed to minimize human error, enhance surgical outcomes, and reduce procedure time. These devices employ cutting-edge technology, such as robotics and artificial intelligence, to ensure accurate and consistent suturing.
One of the primary advantages of automated suturing devices is their precision. These instruments can create uniform and secure sutures, resulting in improved wound healing and reduced risk of complications. The technology allows for more delicate and intricate suturing in hard-to-reach areas, enabling surgeons to perform complex procedures with greater ease and accuracy.
Get your PDF Sample Report with Latest Market Information @ https://www.futuremarketinsights.com/reports/sample/rep-gb-579
It is predicted that the Automated Suturing Devices Market will generate US$ 3.02 billion in 2022 and US$ 6.2 billion by 2032. The market for automated suturing devices is anticipated to grow at a CAGR of 7.46% between 2022 and 2032. The increase of the market can be ascribed to the rise in chronic disease prevalence and the preference for minimally invasive surgeries (MIS) over traditional surgical techniques.
ESOMAR-certified consulting firm Future Market Insight (FMI) presents incisive global automated suturing devices market survey for the forecast period of 2021-2031. According to the report, the market is expected to expand, rising at a CAGR of 7.3 % during the forecast period.
Key Takeaways from FMI’s Automated Suturing Devices Market Study
- The automated suturing devices market in the U.S. will witness positive growth owing to rising prevalence of cardiovascular diseases and requirement for invasive procedures in the country.
- France will find lucrative opportunities during the forecast period as according to the Organization of Economic Cooperation and Development, approximately 148075 minimal invasive surgeries took place in France in 2018. The country also has presence of several manufacturers such as Guerbet, Sanofi, and others.
- Disposable automated suturing devices are expected to lead the product segment as they are cost-effective. Rising demand for laparoscopy and minimally invasive procedures are also encouraging demand for the same.
- Hospitals will exhibit high demand for automated suturing devices since they receive a higher footfall of patients on a daily basis.
“Several leading players are aiming for clearance from the United States Food and Drug Administration to launch advanced automated suturing devices. With focus on technological improvements on cards, the market is expected to gain momentum in the coming years,” says a FMI analyst.
Who is Winning?
Key players in the global automated suturing devices market are focusing on adopting inorganic strategies such as alliance, collaboration, partnerships, and merger and acquisitions to strengthen their position in the supply chain channels.
They are also emphasizing on launching new products and expanding their product portfolio. Key players operating in the global automated suturing devices market are Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc., and SuturTek Inc.
On March 3rd 2020, Origami Surgical launched StitchKit, a patented suture delivery and retrieval system. The U.S. Food and Drug Administration (FDA) approved 510k clearance for three novel types of sutures for the company’s StitchKit robotic surgery platform.
On November 2020, Healthium Medtech, one of India’s largest medical devices company, launched Trubarb, its latest innovation. This innovation is a knotless tissue closure device that reforms the suturing experience.
On June 1st 2021, Anchora Medical, a Alon Medtech Venture’s company, announced closing of $4.5million financing led by HOYA Corporation and Tal Capital. The funds will be utilized for completing Anchora’s single use laparoscopic suturing devices.
Key Segments:
Product
- Reusable Automated Suturing Devices
- Disposable Automated Suturing Devices
Applications
- Minimally Invasive Surgeries
- Open Surgeries
- Trauma Cases
End Use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
